Megha Katti in

Megha Katti

Login to view DISC.
Head of Business Intelligence and Analytics, Rare Portfolio at Apellis Pharmaceuticals
📍 Boston, Massachusetts, United States

Megha Katti heads Business Intelligence and Analytics for the Rare Portfolio at Apellis Pharmaceuticals. An MBA from Harvard Business School, she specializes in commercial insights and strategic forecasting for rare diseases, with prior leadership roles at Sarepta Therapeutics and Alnylam Pharmaceuticals.

She has deep experience leading commercial opportunity assessments and developing revenue forecasts for multiple pipeline products to guide company investment decisions.

Read the full overview →
Experience
9 Years
Current Role
Head of Business Intelligence and Analytics, Rare Portfolio
Job Level
Mid-senior
Location
Boston, Massachusetts, United States
Personality Overview

How Megha shows up

Communication Style
Decision Approach
Work Preference

Behavioral traits and communication patterns that shape how this person evaluates opportunities, builds trust, and makes decisions in professional settings.

Login to view personality overview.
Priorities

Topics Megha cares about

Rare Disease Strategy
Her current role at Apellis is focused on their "Rare Portfolio, " and her prior experience includes commercializing products for rare diseases.
Commercial Analytics
Her career has centered on leading commercial insights and analytics teams at multiple pharmaceutical companies to drive strategy.
+4 more topics Login to view topics
Career

Work history

9-2025
Head of Business Intelligence and Analytics, Rare Portfolio
Apellis Pharmaceuticals
3-2025 - 9-2025
Senior Director, Commercial Insights & Analytics
Sarepta Therapeutics
9-2022 - 3-2025
Director, Commercial Insights & Analytics
Sarepta Therapeutics
3-2022 - 8-2022
Associate Director, New Product Commercialization Insights Lead
Alnylam Pharmaceuticals
9-2019 - 3-2022
Associate Director, Market Insights: TTR Forecasting and Performance Lead
Alnylam Pharmaceuticals
In the press

Media appearances

No media yetWe could not find public media appearances for this person.
Education
Master of Business Administration (MBA)
Harvard Business School
2004 - 2008
ScB
Brown University
Social presence
in
Behavioral profile

DISC profile (public)

DISC behavioral profile

Dominance, influence, steadiness, and calculativeness scores with guidance on how this person prefers to communicate and decide.

Login to view DISC.

Other Apellis Pharmaceuticals Employees

Explore more public profiles from related professionals.

DE
David Eyerman
Head of Research and Nonclinical Development
Apellis Pharmaceuticals
 Joseph LaCognata
Joseph LaCognata
Executive Account Manager, Rare Disease (Hematology / Nephrology / Transplant)
Apellis Pharmaceuticals
 Lisa Wheeler
Lisa Wheeler
Rare Disease Account Manager
Apellis Pharmaceuticals
 Joe Gubbins
Joe Gubbins
Regional Sales Director
Apellis Pharmaceuticals

More profiles

Discover additional public profiles from our index.

JA
Jhocelyn Alvarado
Enrollment Marketing Manager
Lamar University
 Tess Speirs
Tess Speirs
Director of Marketing Operations
Brother USA
DK
David Ketelhut
Manager of Sales Operations
Ally
 Kevin Cattell
Kevin Cattell
Chief Synergy Architect
Red Hat
Unlock the full playbookSee exactly how to sell to Megha. Free, 10 seconds.